Patent US4544439A successfully refreshed from Google Patents.
Patent US5091392A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5091392A Expired / Lapsed US ⏱️ 0.0 years remaining

Substituted (quinolin-2-yl-methoxy)phenyl-acyl-sulphon-amides and -cyanamides, processes for their preparation and their use in medicaments

Assignee: Bayer AG
•
Filing: 1990-05-01
•
Granted: 1992-02-25
•
Expires: 2010-05-01
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A quinolin-2-yl-methoxy)phenylacyl-sulphonamide or -cyanamide of the formula ##STR1## in which A, B, D, E, F and G are identical or different and represent hydrogen, hydroxyl, halogen, carboxyl, nitro, trifluoromethyl, trifluoromethoxy or a group of the formula --NH 3 R 4 , in which R 3 and R 4 are identical or different and denote hydrogen, straight-chain or branched alkyl having up to 8 carbon atoms or aryl having 6 to 10 carbon atoms, represent straight-chain or branched alkyl, alkoxy or alkoxycarbonyl in each case having up to 12 carbon atoms, represent aryl having 6 to 10 carbon atoms, R 1 represents cycloalkyl having 3 to 8 carbon atoms, R 2 represents hydrogen or straight-chain or branched alkyl having up to 10 carbon atoms, represents an alkali metal, represents cycloalkyl having 3 to 8 carbon atoms, X represents a group of the formula --SO 2 --R 5 , in which R 5 denotes trifluoromethyl or straight-chain or branches alkyl having up to 10 carbon atoms, or denotes aryl having 6 to 10 carbon atoms, or X represents cyano and physiologically acceptable salts thereof. The (quinolin-2-yl-methoxy)phenylacylsulphonamide or -cyanamide is useful as an active compound in medicaments, particularly as a lipoxygenase inhibitor.

Inventors

  • 👤 Siegfried Raddatz
  • 👤 Klaus-Helmut Mohrs
  • 👤 Romanis Fruchtmann
  • 👤 Christian Kohlsdorfer
  • 👤 Pia Theisen-Popp
  • 👤 Reiner Muller-Peddinghaus

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 03:12
CPC Classifications
C; C07; C07D; C07D215/00; C07D215/02; C07D215/12; C07D215/14; C07D215/16; C07D215/20; C07D215/22; A; A61; A61P; A61P1/00; A61P11/00; A61P11/06; A61P17/00; A61P29/00; A61P31/00; A61P31/04; A61P37/00; A61P37/08; A61P43/00; A61P9/00; A61P9/06; A61P9/08; A61P9/10

Claims Analysis

Total Claims: 24
Claim 1
Independent Claim 440 words
A (quinolin-2-yl-methoxy)phenylacyl-sulphonamide or -cyanamide of the formula ##STR37## in which A, B, D, E, F and G are identical or different and represent hydrogen, hydroxyl, halogen, carboxyl, nitro, trifluoromethyl, trifluoromethoxy or a group of the formula --NR 3 R 4 , in which R 3 and R 4 are identical or different and denote hydrogen, straight-chain or branched alkyl having up to 8 carbon atoms or aryl having 6 to 10 carbon atoms, represent straight-chain or branched alkyl, alkoxy or alkoxycarbonyl, in each case having up to 12 carbon atoms, and each of which is unsubstituted or substituted by hydroxyl, halogen, nitro, cyano or a group of the formula --NR 3 R 4 , in which R 3 and R 4 have the abovementioned meanings, represent aryl having 6 to 10 carbon atoms, which is unsubstituted or substituted by halogen, hydroxyl, nitro, cyano, straight-chain or branched alkyl, alkoxy or alkoxycarbonyl in each case having up to 8 carbon atoms or by a group of the formula --NR 3 R 4 , in which R 3 and R 4 have the abovementioned meanings, R 1 represents cycloalkyl having 3 to 8 carbon atoms, which is unsubstituted or substituted by straight-chain or branched alkyl having up to 8 carbon atoms, R 2 represents hydrogen or straight-chain or branched alkyl having up to 10 carbon atoms, which is unsubstituted or substituted by hydroxyl, alkoxy having up to 8 carbon atoms, halogen or by cycloalkyl having 3 to 8 carbon atoms or aryl having 6 to 10 carbon atoms, which in turn is unsubstituted or substituted by straight-chain or branched alkyl having up to 8 carbon atoms, halogen, nitro, hydroxyl or cyano, or represents cycloalkyl having 3 to 8 carbon atoms which is unsubstituted or substituted by straight-chain or branched alkyl having up to 8 carbon atoms, or represents an alkali metal, X represents a group of the formula --SO 2 --R 5 , in which R 5 is trifluoromethyl or straight-chain or branched alkyl having up to 10 carbon atoms, which is unsubstituted or substituted by hydroxyl, halogen, cyano, alkoxy or alkoxycarbonyl in each case having up to 8 carbon atoms or by aryl having 6 to 10 carbon atoms, which is unsubstituted or substituted by halogen, nitro, cyano or straight-chain or branched alkyl or alkoxy in each case having up to 8 carbon atoms, or is aryl having 6 to 10 carbon atoms, which is unsubstituted or substituted by halogen, nitro, cyano, hydroxyl, straight-chain or branched alkyl, alkoxy or alkoxycarbonyl in each case having up to 8 carbon atoms, trifluoromethyl or trifluoromethoxy, or X represents cyano or a physiologically acceptable salt thereof.
Claim 2
Dependent Claim 440 words
A (quinolin-2-yl-methoxy)phenylacyl-sulphonamide or -cyanamide of the formula ##STR37## in which A, B, D, E, F and G are identical or different and represent hydrogen, hydroxyl, halogen, carboxyl, nitro, trifluoromethyl, trifluoromethoxy or a group of the formula --NR 3 R 4 , in which R 3 and R 4 are identical or different and denote hydrogen, straight-chain or branched alkyl having up to 8 carbon atoms or aryl having 6 to 10 carbon atoms, represent straight-chain or branched alkyl, alkoxy or alkoxycarbonyl, in each case having up to 12 carbon atoms, and each of which is unsubstituted or substituted by hydroxyl, halogen, nitro, cyano or a group of the formula --NR 3 R 4 , in which R 3 and R 4 have the abovementioned meanings, represent aryl having 6 to 10 carbon atoms, which is unsubstituted or substituted by halogen, hydroxyl, nitro, cyano, straight-chain or branched alkyl, alkoxy or alkoxycarbonyl in each case having up to 8 carbon atoms or by a group of the formula --NR 3 R 4 , in which R 3 and R 4 have the abovementioned meanings, R 1 represents cycloalkyl having 3 to 8 carbon atoms, which is unsubstituted or substituted by straight-chain or branched alkyl having up to 8 carbon atoms, R 2 represents hydrogen or straight-chain or branched alkyl having up to 10 carbon atoms, which is unsubstituted or substituted by hydroxyl, alkoxy having up to 8 carbon atoms, halogen or by cycloalkyl having 3 to 8 carbon atoms or aryl having 6 to 10 carbon atoms, which in turn is unsubstituted or substituted by straight-chain or branched alkyl having up to 8 carbon atoms, halogen, nitro, hydroxyl or cyano, or represents cycloalkyl having 3 to 8 carbon atoms which is unsubstituted or substituted by straight-chain or branched alkyl having up to 8 carbon atoms, or represents an alkali metal, X represents a group of the formula --SO 2 --R 5 , in which R 5 is trifluoromethyl or straight-chain or branched alkyl having up to 10 carbon atoms, which is unsubstituted or substituted by hydroxyl, halogen, cyano, alkoxy or alkoxycarbonyl in each case having up to 8 carbon atoms or by aryl having 6 to 10 carbon atoms, which is unsubstituted or substituted by halogen, nitro, cyano or straight-chain or branched alkyl or alkoxy in each case having up to 8 carbon atoms, or is aryl having 6 to 10 carbon atoms, which is unsubstituted or substituted by halogen, nitro, cyano, hydroxyl, straight-chain or branched alkyl, alkoxy or alkoxycarbonyl in each case having up to 8 carbon atoms, trifluoromethyl or trifluoromethoxy, or X represents cyano or a physiologically acceptable salt thereof.
Claim 3
Dependent Claim 419 words
A (quinolin-2-yl-methoxy)phenylacyl-sulphonamide or -cyanamide of the formula (I) according to claim 1 in which A, B, D, E, F and G are identical different and represent hydrogen, hydroxyl, fluorine, chlorine, bromine, carboxyl, nitro, trifluoromethyl, trifluoromethoxy or a group of the formula --NR 3 R 4 , in which R 3 and R 4 are identical or different and denote hydrogen, straight-chain or branched alkyl having up to 6 carbon atoms or phenyl, represent straight-chain or branched alkyl, alkoxy or alkoxycarbonyl in each case having up to 10 carbon atoms, and each of which is unsubstituted or substituted by hydroxyl, fluorine, chlorine, bromine, nitro, cyano or a group of the formula --NR 3 R 4 , in which R 3 and R 4 have the abovementioned meanings, represent phenyl which is unsubstituted or substituted by fluorine, chlorine, bromine, hydroxyl, nitro, cyano, straight-chain or branched alkyl, alkoxy or alkoxycarbonyl in each case having up to 6 carbon atoms or by a group of the formula --NR 3 R 4 , in which R 3 and R 4 have the abovementioned meanings, R 1 represents cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl or cycloheptyl, each of which is unsubstituted or substituted by straight-chain or branched alkyl having up to 6 carbon atoms, R 2 represents hydrogen or straight-chain or branched alkyl having up to 8 carbon atoms, which is unsubstituted or substituted by hydroxyl, alkoxy having up to 6 carbon atoms, fluorine, chlorine, bromine, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl or phenyl, which in turn is unsubstituted or substituted by straight-chain or branched alkyl having up to 6 carbon atoms, fluorine, chlorine or bromine, or represents cyclopropyl, cyclohexyl, cyclopentyl, cyclohexyl or cycloheptyl, each of which is unsubstituted or substituted by straight-chain or branched alkyl having up to 6 carbon atoms, or represents sodium or potassium, X represents a group of the formula --SO 2 --R 5 , in which R 5 is trifluoromethyl or straight-chain or branched alkyl having up to 8 carbon atoms, which is unsubstituted or substituted by fluorine, chlorine, bromine, alkoxycarbonyl in each case having up to 6 carbon atoms or by phenyl, which in turn is unsubstituted or substituted by fluorine, chlorine, bromine or by straight-chain or branched alkyl or alkoxy in each case having up to 6 carbon atoms, or is phenyl which is unsubstituted or substituted by fluorine, chlorine, bromine, nitro, cyano, straight-chain or branched alkyl, alkoxy or alkoxycarbonyl in each case having up to 6 carbon atoms or trifluoromethyl, or X represents cyano or a physiologically acceptable salt thereof.
Claim 4
Dependent Claim 186 words
A (quinolin-2-yl-methoxy)phenylacyl-sulphonamide or -cyanamide of the formula (I) according to claim 1 in which A, B, D, E, F and G are identical or different and represent hydrogen, fluorine, chlorine, bromine, nitro or trifluoromethyl, represent methyl, ethyl, propyl, isopropyl, butyl or tert.butyl, R 1 represents cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl or cycloheptyl, each of which is unsubstituted or substituted by methyl, ethyl, propyl or isopropyl, R 2 represents hydrogen or straight-chain or branched alkyl having up to 6 carbon atoms, which is unsubstituted or substituted by cyclopropyl, cyclopentyl, cyclohexyl or cycloheptyl, represents cyclopropyl, cyclopentyl, cyclohexyl or cycloheptyl, or represents sodium, X represents a group of the formula --SO 2 --R 5 , in which R 5 is trifluoromethyl, straight-chain or branched alkyl having up to 6 carbon atoms, which is unsubstituted or substituted by phenyl which in turn is substituted by fluorine, chlorine or by straight-chain or branched alkyl having up to 4 carbon atoms, or is phenyl which is unsubstituted or substituted by fluorine, chlorine or straight-chain or branched alkyl having up to 4 carbon atoms, or X represents cyano or a physiologically acceptable salt thereof.
Claim 5
Dependent Claim 5 words
N-{1-[4-(Quinolin-2-yl-methoxy)phenyl]-1-cyclopentyl}-acetyl-o-tolylsulphonamide of the formula ##STR38##
Claim 6
Dependent Claim 5 words
N-{1-[4-(Quinolin-2-yl-methoxy)phenyl]-1-cyclopentyl}-acetyl-o-tolylsulphonamide of the formula ##STR38##
Claim 7
Dependent Claim 5 words
N-{1-[4-(Quinolin-2-yl-methoxy)phenyl]-1-cyclopentyl}-acetyl-trifluoromethanesulphonamide of the formula ##STR39##
Claim 8
Dependent Claim 5 words
N-{1-[4-(Quinolin-2-yl-methoxy)phenyl]-1-cyclopentyl}-acetyl-trifluoromethanesulphonamide of the formula ##STR39##
Claim 9
Dependent Claim 5 words
N-Methyl-N-{1-[4-(quinolin-2-yl-methoxy)phenyl]-1-cyclopentyl-acetyl-}-trifluoromethanesulphonamide of the formula ##STR40##
Claim 10
Dependent Claim 5 words
N-Methyl-N-{1-[4-(quinolin-2-yl-methoxy)phenyl]-1-cyclopentyl-acetyl-}-trifluoromethanesulphonamide of the formula ##STR40##
Claim 11
Dependent Claim 5 words
N-{1-[4-(Quinolin-2-yl-methoxy)phenyl]-1-cyclopentyl}-acetyl-cyanamide of the formula ##STR41##
Claim 12
Dependent Claim 5 words
N-{1-[4-(Quinolin-2-yl-methoxy)phenyl]-1-cyclopentyl}-acetyl-cyanamide of the formula ##STR41##
Claim 13
Dependent Claim 37 words
A composition for inhibiting enzymatic reactions in the context of arachidonic acid metabolism consisting essentially of an enzymatic inhibitory effective amount of a (quinolin-2-yl-methoxy)phenylacyl-sulphonamide or -cyanamide according to claim 1 in admixture with a pharmaceutically acceptable carrier.
Claim 14
Dependent Claim 19 words
A unit dose of a composition according to claim 8 in the form of a tablet, capsule or ampoule.
Claim 15
Dependent Claim 47 words
A method of inhibiting enzymatic reactions in the context of arachidonic acid metabolism in a patient consisting essentially of administering to said patient an enzymatic inhibitory effective amount of a (quinolin-2-yl-methoxy)phenylacyl-sulphonamide or -cyanamide according to claim 1, either alone or in admixture with a physiologically acceptable diluent.
Claim 16
Dependent Claim 23 words
A method according to claim 10, wherein the (quinolin-2-yl-methoxy)phenylacyl-sulphonamide or -cyanamide is selected from the group consisting of N-{1-[4-quinolin-2-yl-methoxy)phenyl]-1-cyclopentyl}-acetyl-o-tolylsulphonamide, N-{1-[4-quinolin-2-yl-methoxy)phenyl]-1-cyclopentyl}-acetyl-trifluoromethanesulphonamide, N-methyl-N-{1-[4-(quinolin-2-yl-methoxy)phenyl]-1-cyclopentyl-acetyl}-trifluoromethanesulphonamide, and N-{1-[4-quinolin-2-yl-methoxy)phenyl]-1-cyclopentyl}-acetyl-cyanamide.
Claim 17
Dependent Claim 19 words
A method according to claim 11, wherein the enzymatic reaction in the context of arachidonic acid metabolism is lipoxygenase.
Claim 18
Dependent Claim 58 words
A method of treating a patient suffering from allergies, bronchitis, emphysema, shock lung, pulmonary hypertension, inflammation, oedemas, thromboses, thromboemolisms, ischaemias, cardiac infarct, cerebral infarct, cardiac arrhythmia, angina pectoris, arteriosclerosis or dermatoses comprising administering to said patient an effective amount of a (quinolin-2-yl-methoxy)-phenylacyl-sulphonamide or -cyanamide according to claim 1, either alone or in admixture with a physiologically acceptable diluent.
Claim 19
Dependent Claim 23 words
A method according to claim 13, wherein the (quinolin-2-yl-methoxy)phenylacyl-sulphonamide or -cyanamide is selected from the group consisting of N-{1-[4-(quinolin-2-yl-methoxy)phenyl]-1-cyclopentyl}-acetyl-o-tolylsulphonamide, N-{1-[4-(quinolin-2-yl-methoxy)phenyl]-1-cyclopentyl}-acetyl-trifluoromethanesulphonamide, N-methyl-N-{1-[4-(quinolin-2-yl-methoxy)phenyl]-1-cyclopentyl-acetyl}-trifluoromethanesulphonamide, and N-{1-[4-(quinolin-2-yl-methoxy)phenyl]-1-cyclopentyl}-acetyl-cyanamide.
Claim 20
Dependent Claim 12 words
(+)-Enantiomeres and (-)-Enantiomeres of substituted (quinoline-2-yl-methoxy)phenyl-acyl-sulfonamides and -cyanamides according to claim 1.
Claim 21
Dependent Claim 1 words
(+)-N-[1-[4-(Quinoline-2-yl-methoxy)phenyl-1-cycloheptyl]-acetyl-methanesulfonamide.
Claim 22
Dependent Claim 1 words
(+)-N-[1-[4-(Quinoline-2-yl-methoxy)phenyl-1-cycloheptyl]-acetyl-methanesulfonamide.
Claim 23
Dependent Claim 1 words
(-)-N-[1-[4-Quinoline-2-yl-methoxy)phenyl-1-cycloheptyl]-acetyl-methanesulfonamide.
Claim 24
Dependent Claim 1 words
(-)-N-[1-[4-Quinoline-2-yl-methoxy)phenyl-1-cycloheptyl]-acetyl-methanesulfonamide.

References Cited (Backward Citations)

EP0219308A2 Cited
GB2202223A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1995-02-24 1995-08-26 1996-02-25 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1999-02-24 1999-08-26 2000-02-25 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2003-02-24 2003-08-26 2004-02-25 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag